share_log

綠葉製藥:自願性公告 - (BA5101)在中國進入III期臨床試驗

LUYE PHARMA: VOLUNTARY ANNOUNCEMENT - DULAGLUTIDE INJECTION (BA5101) ENTERED INTO PHASE III CLINICAL TRIAL IN CHINA

Jul 14, 2022 10:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more